
What Bluesight’s Acquisition Means for Former Protenus Customers
The drug diversion software market does not shift often, but when it does, healthcare organizations feel it quickly. For teams now reevaluating vendors after the

The drug diversion software market does not shift often, but when it does, healthcare organizations feel it quickly. For teams now reevaluating vendors after the

Interviewing healthcare workers suspected of diversion is one of the highest-stakes moments in any investigation. In this episode of Diversion Insights, Terri Vidals sits down

DEA inspections of healthcare facilities are increasing. Hospitals, surgery centers, and pharmacies are seeing more routine accountability audits, diversion investigations, and cyclic inspections than they

The Role of Drug Diversion Monitoring Software in 2025 Mitigation Strategies The drug diversion software market has changed more in the past three years than

Drug diversion rarely happens because of one obvious failure. In most healthcare organizations, it develops through small control gaps that go unnoticed over time: inconsistent

The more addiction and recovery stories healthcare leaders hear, the harder it becomes to reduce substance use disorder to a stereotype. That is exactly why

In a recent RXPERT podcast discussion, diversion mitigation leaders explored a question many healthcare organizations still wrestle with: what actually makes someone effective in a
© Copyright 2026. All Rights Reserved.